Compare Avient Corporation (AVNT) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avient Corporation vs Citius Pharmaceuticals Inc — how do they compare? Avient Corporation trades at $45.37 (market cap $4.17B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Avient Corporation is far larger — about 208.4× Citius Pharmaceuticals Inc's market cap, and Avient Corporation pays a 2.42% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AVNT | CTXR | |
|---|---|---|
Market Cap | $4.17B | $20.01M |
Sector | Technology | Health |
52-Week High | $45.69 | $1.82 |
52-Week Low | $27.48 | $0.48 |
Enterprise Value | $5.62B | $16.23M |
Dividend Yield | 2.42% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Avient Corporation
Avient Corporation is a global leader in specialized and sustainable material solutions. Formed from the legacy of PolyOne and Clariant’s masterbatch business, it provides highly engineered polymer formulations, color systems, and advanced composites that enhance the performance and sustainability of products in industries like healthcare, defense, and consumer packaging.
Read more on AVNT →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
